Patents by Inventor Bhanu Priya Ganesh

Bhanu Priya Ganesh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230241136
    Abstract: The invention herein discloses histamine-producing bacterial strains for use in the prophylaxis, inhibition, treatment or reducing a risk of relapse of cancer, including colorectal cancer. The present invention also discloses the use of histamine-producing bacterial strains for manufacturing a medicament for treatment of cancer, including male colorectal cancer.
    Type: Application
    Filed: December 1, 2022
    Publication date: August 3, 2023
    Inventors: James Versalovic, Bo Mollstam, Chunxu Gao, Bhanu Priya Ganesh
  • Publication number: 20220008491
    Abstract: Bacterial strains useful in prophylaxis, inhibition and/or treatment of an allergy in a mammal are selected by screening bacterial strains for capability of producing diacylglycerol kinase (DagK). A bacterial strain which is capable of producing DagK is then selected for use in prophylaxis, inhibition and/or treatment of the allergy.
    Type: Application
    Filed: August 31, 2021
    Publication date: January 13, 2022
    Inventors: James Versalovic, Bo Mollstam, Bhanu Priya Ganesh
  • Patent number: 11135255
    Abstract: Bacterial strains useful in prophylaxis, inhibition and/or treatment of an allergy in a mammal are selected by screening bacterial strains for capability of producing diacylglycerol kinase (DagK). A bacterial strain which is capable of producing DagK is then selected for use in prophylaxis, inhibition and/or treatment of the allergy.
    Type: Grant
    Filed: May 8, 2017
    Date of Patent: October 5, 2021
    Assignee: BIOGAIA AB
    Inventors: James Versalovic, Bo Mollstam, Bhanu Priya Ganesh
  • Publication number: 20190142877
    Abstract: Bacterial strains useful in prophylaxis, inhibition and/or treatment of an allergy in a mammal are selected by screening bacterial strains for capability of producing diacylglycerol kinase (DagK). A bacterial strain which is capable of producing DagK is then selected for use in prophylaxis, inhibition and/or treatment of the allergy.
    Type: Application
    Filed: May 8, 2017
    Publication date: May 16, 2019
    Inventors: James Versalovic, Bo Mollstam, Bhanu Priya Ganesh